Applied Therapeutics, Inc. 8-K Report: Key Updates & Insights (Dec 19, 2024)

Here’s a summary of the key information extracted from the provided section of the financial report:

1. Entity Information:

• Company Name: Applied Therapeutics, Inc.
• CIK (Central Index Key): 0001697532
• State of Incorporation: Delaware (DE)
• SEC File Number: 001-38898
• EIN (Employer Identification Number): 81-3405262
• Address: 545 Fifth Avenue, Suite 1400, New York, NY 10017
• Phone Number: 212-220-9226

2. Filing Details:

• Filing Type: 8-K (Current Report)
• Filing Date: December 19, 2024

3. Stock Information:

• Common Stock Ticker Symbol: APLT
• Exchange: NASDAQ

4. Reporting Period:

• Start Date: December 19, 2024
• End Date: December 19, 2024

5. XBRL Schema:

• The report is structured in XBRL (eXtensible Business Reporting Language) format, which allows for easier data extraction and analysis.

Insights:

• The filing date coincides with the period covered, indicating that this might be an immediate disclosure of significant events or changes affecting the company.
• The use of the 8-K form suggests that there may be noteworthy developments to disclose to investors or regulators.
• The company is publicly traded on NASDAQ under the ticker APLT, which provides context for its market visibility and investor engagement.

This summary captures the essential details and context of the filing, which could be pertinent for further analysis or investor consideration.